Published in J Antimicrob Chemother on June 02, 2004
Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med (2007) 2.19
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy. BMC Clin Pharmacol (2006) 1.22
Accelerated metabolism of voriconazole and its partial reversal by cimetidine. Antimicrob Agents Chemother (2009) 1.05
Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy. Crit Care (2015) 1.03
Voriconazole pharmacokinetics in liver transplant recipients. Antimicrob Agents Chemother (2009) 0.92
Presence and accuracy of drug dosage recommendations for continuous renal replacement therapy in tertiary drug information references. Can J Hosp Pharm (2012) 0.75
Dosing Recommendations for Continuous Venovenous Hemodiafiltration with AN69 Filter Membranes and Prismaflex Dialyzers. Can J Hosp Pharm (2009) 0.75
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS (2001) 5.52
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone Marrow Transplant (2010) 3.46
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med (2001) 2.91
Status epilepticus: an independent outcome predictor after cerebral anoxia. Neurology (2007) 2.67
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG (2012) 2.14
Prevalence and determinants of QT interval prolongation in medical inpatients. Intern Med J (2012) 2.01
Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels. Leukemia (2007) 1.89
Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther (2002) 1.69
Risk factors of sensorineural hearing loss in preterm infants. Biol Neonate (1997) 1.63
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals. Clin Pharmacol Ther (2009) 1.57
Inosine improves gut permeability and vascular reactivity in endotoxic shock. Crit Care Med (2001) 1.57
Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods? Clin Pharmacokinet (2001) 1.48
Effects of norepinephrine on the distribution of intestinal blood flow and tissue adenosine triphosphate content in endotoxic shock. Crit Care Med (2000) 1.47
Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein. Br J Clin Pharmacol (2006) 1.46
Psychopharmacology in supportive care of cancer: a review for the clinician. III. Antidepressants. Support Care Cancer (2000) 1.45
Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res (2001) 1.39
Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J Clin Microbiol (2010) 1.38
Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma. Clin Chem (2001) 1.27
Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res (2001) 1.22
Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.20
Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med (2001) 1.19
Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability. Br J Cancer (2008) 1.13
Influence of perinatal, developmental and environmental factors on cognitive abilities of preterm children without major impairments at 5 years. Early Hum Dev (1995) 1.11
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study. Bone Marrow Transplant (2010) 1.11
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.10
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers. J Interferon Cytokine Res (2000) 1.09
Response to: lack of intra-laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen. Transpl Infect Dis (2011) 1.09
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers. J Neuroimmunol (1999) 1.09
Surgical treatment of primary and metastatic sternal tumours. J Cardiovasc Surg (Torino) (2001) 1.07
Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes. J Mol Cell Cardiol (2005) 1.05
Negative pressure post-tracheal extubation alveolar hemorrhage. Anesth Analg (2001) 1.03
Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection. Lancet (1996) 1.03
The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol (1999) 1.03
Inosine reduces inflammation and improves survival in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol (2002) 1.02
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability. Ther Drug Monit (2001) 1.02
NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J Endocrinol (2002) 1.02
A comparative study of reactive hyperemia in human forearm skin and muscle. Physiol Res (2007) 1.02
Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther (2001) 1.01
Tracheobronchial laceration after double-lumen intubation for thoracic procedures. Ann Thorac Surg (1998) 1.00
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae. Antimicrob Agents Chemother (2000) 0.99
Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Clin Infect Dis (2007) 0.97
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. J Antimicrob Chemother (2009) 0.96
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer (2013) 0.96
Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement. Chest (2000) 0.93
Drug points: severe ergotism associated with interaction between ritonavir and ergotamine. BMJ (1999) 0.93
Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients. J Clin Pharmacol (2003) 0.92
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration. Cancer Chemother Pharmacol (1998) 0.92
Population pharmacokinetic study of isepamicin with intensive care unit patients. Antimicrob Agents Chemother (1996) 0.91
Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.91
Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.90
Population pharmacokinetic study of teicoplanin in severely neutropenic patients. Antimicrob Agents Chemother (1996) 0.90
Clinical pharmacokinetics of diacerein. Clin Pharmacokinet (1998) 0.90
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clin Infect Dis (2003) 0.89
Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis. Antimicrob Agents Chemother (1998) 0.88
High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrob Agents Chemother (2010) 0.88
Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. Forensic Sci Int (2001) 0.88
CT-guided transthoracic needle biopsy in the diagnosis of chest tumours. J Cardiovasc Surg (Torino) (1997) 0.87
Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide. Eur J Clin Pharmacol (1995) 0.87
Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. Synthesis and pharmacological evaluation of a Y2 antagonist. J Biol Chem (1997) 0.86
Right arm involvement and pain extension can help to differentiate coronary diseases from chest pain of other origin: a prospective emergency ward study of 278 consecutive patients admitted for chest pain. J Intern Med (1990) 0.85
Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae. J Antimicrob Chemother (1998) 0.85
[Volatile hydrocarbons in exhaled air: preliminary data on the characteristic profile associated with lung tumors]. G Ital Med Lav Ergon (2004) 0.85
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir. Antimicrob Agents Chemother (2009) 0.84
Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction. J Chromatogr B Biomed Sci Appl (2000) 0.84
Leiomyosarcoma of the superior vena cava. Ann Thorac Surg (1996) 0.84
Surgical outcome of combined pulmonary and atrial resection for lung cancer. Thorac Cardiovasc Surg (2004) 0.84
Ceftriaxone pharmacokinetics during iatrogenic hydroxyethyl starch-induced hypoalbuminemia: a model to explore the effects of decreased protein binding capacity on highly bound drugs. Anesthesiology (2000) 0.83
Fractional excretion of trace lithium and uric acid in acute renal failure. J Am Soc Nephrol (1994) 0.83
Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies. Antimicrob Agents Chemother (2008) 0.83
Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Respir Crit Care Med (1998) 0.83
Biological variables in non-small cell lung cancer: comparison between immunocytochemical determination on fine needle aspirates from surgical specimens and immunohistochemical determination on tissue sections. Lung Cancer (2000) 0.83
[Anterior segment necrosis in multidrug-resistant Fusarium keratomycosis: a case study]. J Fr Ophtalmol (2005) 0.83
Psychopharmacology in supportive care of cancer: a review for the clinician: II. Neuroleptics. Support Care Cancer (2000) 0.82
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients. Eur J Clin Microbiol Infect Dis (2005) 0.82
Clinical pharmacokinetics and pharmacodynamics of isepamicin. Clin Pharmacokinet (2000) 0.82
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients. J Antimicrob Chemother (2008) 0.81
Imatinib plasma levels: correlation with clinical benefit in GIST patients. Br J Cancer (2010) 0.81
Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line. Cancer Lett (2006) 0.81
Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma. J Nucl Med (1995) 0.81
Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo. J Antimicrob Chemother (1997) 0.81
Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists. Clin Pharmacokinet (1997) 0.81
Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography. Ther Drug Monit (2001) 0.81
Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock. Shock (2000) 0.81
Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine. Int J Antimicrob Agents (2008) 0.81
Quantitative characterization of the growth of the fetal kidney. J Clin Ultrasound (1983) 0.81
Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers. J Cardiovasc Pharmacol (1998) 0.80
NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios. Br J Clin Pharmacol (2003) 0.80
Histological and immunohistochemical study of the bronchial stump with flap coverage in an animal model. Eur Surg Res (2003) 0.80
Spontaneous rupture of the spleen during malaria treated with transcatheter coil embolization of the splenic artery. Intensive Care Med (2002) 0.80
High-performance liquid chromatography of the renal blood flow marker p-aminohippuric acid (PAH) and its metabolite N-acetyl PAH improves PAH clearance measurements. J Chromatogr B Biomed Sci Appl (1997) 0.80
A technical proposal for the complex flail chest. Ann Thorac Surg (2000) 0.79
Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients. Eur J Clin Pharmacol (2001) 0.79
Experimental tracheal transplantation using a cryopreserved aortic allograft. Eur Surg Res (1999) 0.79
Omeprazole and lansoprazole are not inducers of cytochrome P4501A2 under conventional therapeutic conditions. Eur J Clin Pharmacol (1996) 0.79
L-canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats. Crit Care Med (1997) 0.79
Pneumomediastinum following Politzer's manoeuvre. Thorax (1996) 0.79